Cancer Targeting Therapies: Conventional and Advanced Perspectives
This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advance...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Taylor & Francis
2024
|
| Schriftenreihe: | Drugs and the Pharmaceutical Sciences
|
| Schlagworte: | |
| Zusammenfassung: | This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.Features- Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes- Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries- Draws on the author's vast experience in the field of industrial hygiene and hazardous materials- Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues- Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates |
| Beschreibung: | - History of Cancer Therapies ; - Cancer and Carcinogens ; - Causes of Death from Cancer ; - Passive Targeting ; - Cancer Active Targeting Strategies ; Conventional Cancer Therapies; - Oral Anticancer Therapies ; - Parenteral Anticancer Therapies ; Advanced Cancer Therapies; - The Advent of Micro and Nano-spheres for Cancer Treatment ; - The Emergence of Liposomes in Cancer Therapy ; - Niosomes-Based Anticancer Therapies ; - Solid Lipid Nanoparticles-Based Anticancer Therapies ; - Mesoporous Nanoparticles-Based Anticancer Therapies; - Antibody-Based Cancer Therapies ; - Aptamer-Based Anticancer Therapies ; - Polyamidoamines-Based Anticancer Therapies ; - Photodynamic Therapies for Cancer Treatment |
| Beschreibung: | 312 Seiten 453 gr |
| ISBN: | 9781032427126 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV050145300 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 250129s2024 xx |||| 00||| eng d | ||
| 020 | |a 9781032427126 |9 978-1-03-242712-6 | ||
| 024 | 3 | |a 9781032427126 | |
| 035 | |a (DE-599)BVBBV050145300 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 | ||
| 100 | 1 | |a Ali, Muhammad Yasir |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Cancer Targeting Therapies |b Conventional and Advanced Perspectives |
| 264 | 1 | |b Taylor & Francis |c 2024 | |
| 300 | |a 312 Seiten |c 453 gr | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Drugs and the Pharmaceutical Sciences | |
| 500 | |a - History of Cancer Therapies ; - Cancer and Carcinogens ; - Causes of Death from Cancer ; - Passive Targeting ; - Cancer Active Targeting Strategies ; Conventional Cancer Therapies; - Oral Anticancer Therapies ; - Parenteral Anticancer Therapies ; Advanced Cancer Therapies; - The Advent of Micro and Nano-spheres for Cancer Treatment ; - The Emergence of Liposomes in Cancer Therapy ; - Niosomes-Based Anticancer Therapies ; - Solid Lipid Nanoparticles-Based Anticancer Therapies ; - Mesoporous Nanoparticles-Based Anticancer Therapies; - Antibody-Based Cancer Therapies ; - Aptamer-Based Anticancer Therapies ; - Polyamidoamines-Based Anticancer Therapies ; - Photodynamic Therapies for Cancer Treatment | ||
| 520 | |a This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.Features- Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes- Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries- Draws on the author's vast experience in the field of industrial hygiene and hazardous materials- Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues- Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates | ||
| 650 | 4 | |a bicssc / Biology, life sciences | |
| 650 | 4 | |a bicssc / Pharmaceutical technology | |
| 650 | 4 | |a bicssc / Pharmacology | |
| 650 | 4 | |a bisacsh / MEDICAL / Pharmacy | |
| 650 | 4 | |a bisacsh / SCIENCE / Chemistry / General | |
| 700 | 1 | |a Bukhari, Shazia |e Sonstige |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-035481748 | |
Datensatz im Suchindex
| _version_ | 1822626014113562624 |
|---|---|
| adam_text | |
| any_adam_object | |
| author | Ali, Muhammad Yasir |
| author_facet | Ali, Muhammad Yasir |
| author_role | aut |
| author_sort | Ali, Muhammad Yasir |
| author_variant | m y a my mya |
| building | Verbundindex |
| bvnumber | BV050145300 |
| ctrlnum | (DE-599)BVBBV050145300 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV050145300</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">250129s2024 xx |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781032427126</subfield><subfield code="9">978-1-03-242712-6</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9781032427126</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV050145300</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ali, Muhammad Yasir</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer Targeting Therapies</subfield><subfield code="b">Conventional and Advanced Perspectives</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Taylor & Francis</subfield><subfield code="c">2024</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">312 Seiten</subfield><subfield code="c">453 gr</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Drugs and the Pharmaceutical Sciences</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">- History of Cancer Therapies ; - Cancer and Carcinogens ; - Causes of Death from Cancer ; - Passive Targeting ; - Cancer Active Targeting Strategies ; Conventional Cancer Therapies; - Oral Anticancer Therapies ; - Parenteral Anticancer Therapies ; Advanced Cancer Therapies; - The Advent of Micro and Nano-spheres for Cancer Treatment ; - The Emergence of Liposomes in Cancer Therapy ; - Niosomes-Based Anticancer Therapies ; - Solid Lipid Nanoparticles-Based Anticancer Therapies ; - Mesoporous Nanoparticles-Based Anticancer Therapies; - Antibody-Based Cancer Therapies ; - Aptamer-Based Anticancer Therapies ; - Polyamidoamines-Based Anticancer Therapies ; - Photodynamic Therapies for Cancer Treatment</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.Features- Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes- Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries- Draws on the author's vast experience in the field of industrial hygiene and hazardous materials- Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues- Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">bicssc / Biology, life sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">bicssc / Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">bicssc / Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">bisacsh / MEDICAL / Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">bisacsh / SCIENCE / Chemistry / General</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bukhari, Shazia</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-035481748</subfield></datafield></record></collection> |
| id | DE-604.BV050145300 |
| illustrated | Not Illustrated |
| indexdate | 2025-01-29T23:00:18Z |
| institution | BVB |
| isbn | 9781032427126 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-035481748 |
| open_access_boolean | |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 312 Seiten 453 gr |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Taylor & Francis |
| record_format | marc |
| series2 | Drugs and the Pharmaceutical Sciences |
| spelling | Ali, Muhammad Yasir Verfasser aut Cancer Targeting Therapies Conventional and Advanced Perspectives Taylor & Francis 2024 312 Seiten 453 gr txt rdacontent n rdamedia nc rdacarrier Drugs and the Pharmaceutical Sciences - History of Cancer Therapies ; - Cancer and Carcinogens ; - Causes of Death from Cancer ; - Passive Targeting ; - Cancer Active Targeting Strategies ; Conventional Cancer Therapies; - Oral Anticancer Therapies ; - Parenteral Anticancer Therapies ; Advanced Cancer Therapies; - The Advent of Micro and Nano-spheres for Cancer Treatment ; - The Emergence of Liposomes in Cancer Therapy ; - Niosomes-Based Anticancer Therapies ; - Solid Lipid Nanoparticles-Based Anticancer Therapies ; - Mesoporous Nanoparticles-Based Anticancer Therapies; - Antibody-Based Cancer Therapies ; - Aptamer-Based Anticancer Therapies ; - Polyamidoamines-Based Anticancer Therapies ; - Photodynamic Therapies for Cancer Treatment This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.Features- Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes- Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries- Draws on the author's vast experience in the field of industrial hygiene and hazardous materials- Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues- Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates bicssc / Biology, life sciences bicssc / Pharmaceutical technology bicssc / Pharmacology bisacsh / MEDICAL / Pharmacy bisacsh / SCIENCE / Chemistry / General Bukhari, Shazia Sonstige oth |
| spellingShingle | Ali, Muhammad Yasir Cancer Targeting Therapies Conventional and Advanced Perspectives bicssc / Biology, life sciences bicssc / Pharmaceutical technology bicssc / Pharmacology bisacsh / MEDICAL / Pharmacy bisacsh / SCIENCE / Chemistry / General |
| title | Cancer Targeting Therapies Conventional and Advanced Perspectives |
| title_auth | Cancer Targeting Therapies Conventional and Advanced Perspectives |
| title_exact_search | Cancer Targeting Therapies Conventional and Advanced Perspectives |
| title_full | Cancer Targeting Therapies Conventional and Advanced Perspectives |
| title_fullStr | Cancer Targeting Therapies Conventional and Advanced Perspectives |
| title_full_unstemmed | Cancer Targeting Therapies Conventional and Advanced Perspectives |
| title_short | Cancer Targeting Therapies |
| title_sort | cancer targeting therapies conventional and advanced perspectives |
| title_sub | Conventional and Advanced Perspectives |
| topic | bicssc / Biology, life sciences bicssc / Pharmaceutical technology bicssc / Pharmacology bisacsh / MEDICAL / Pharmacy bisacsh / SCIENCE / Chemistry / General |
| topic_facet | bicssc / Biology, life sciences bicssc / Pharmaceutical technology bicssc / Pharmacology bisacsh / MEDICAL / Pharmacy bisacsh / SCIENCE / Chemistry / General |
| work_keys_str_mv | AT alimuhammadyasir cancertargetingtherapiesconventionalandadvancedperspectives AT bukharishazia cancertargetingtherapiesconventionalandadvancedperspectives |